+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Waldenstrom Macroglobulinemia - Pipeline Insight, 2025 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
US General Anesthesia Drugs Market by Route of Administration (Intravenous, Inhalational) and End-user (Hospitals, Ambulatory Surgery Centers) - Forecast to 2025 - Product Thumbnail Image

US General Anesthesia Drugs Market by Route of Administration (Intravenous, Inhalational) and End-user (Hospitals, Ambulatory Surgery Centers) - Forecast to 2025

  • Report
  • February 2021
  • 117 Pages
  • United States
From
Cystic Fibrosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 282 Pages
  • Global
From
Precision Oncology - Global Strategic Business Report - Product Thumbnail Image

Precision Oncology - Global Strategic Business Report

  • Report
  • July 2025
  • 382 Pages
  • Global
From
Breast Adenocarcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Breast Adenocarcinoma Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 294 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
Head and Neck Squamous Cell Carcinoma - Global Strategic Business Report - Product Thumbnail Image

Head and Neck Squamous Cell Carcinoma - Global Strategic Business Report

  • Report
  • July 2025
  • 474 Pages
  • Global
From
Esophageal Squamous Cell Carcinoma - Global Strategic Business Report - Product Thumbnail Image

Esophageal Squamous Cell Carcinoma - Global Strategic Business Report

  • Report
  • July 2025
  • 275 Pages
  • Global
From
Drug Manufacturing Sector Scorecard - Thematic Intelligence - Product Thumbnail Image

Drug Manufacturing Sector Scorecard - Thematic Intelligence

  • Report
  • October 2022
  • 23 Pages
  • Global
From
Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032 - Product Thumbnail Image

Oral Proteins and Peptides Market by Target Disease Indication, Type of Molecule, Technology Platforms, Biological Target, Mechanism of Action, Key Players, and Key Geographical Regions, 2022-2032

  • Report
  • February 2022
  • 421 Pages
  • Global
From
Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type, Drug Type, Route of Administration, and Region 2024-2032 - Product Thumbnail Image

Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type, Drug Type, Route of Administration, and Region 2024-2032

  • Report
  • August 2024
  • 141 Pages
  • Global
From
Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • November 2023
  • 224 Pages
  • Global
From
Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032 - Product Thumbnail Image

Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032

  • Report
  • November 2023
  • 353 Pages
  • Global
From
Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 417 Pages
  • Global
From
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 1834 Pages
  • Global
From
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 4115 Pages
  • Global
From
Ebola Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Drugs and Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 485 Pages
  • Global
From
Angina Pectoris Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Angina Pectoris Treatment Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2022
  • 94 Pages
  • Global
From
Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • February 2024
  • 130 Pages
  • Global
From
Loading Indicator